3 min read
|
Saved February 14, 2026
|
Copied!
Do you care about this?
Tinder is launching an AI-driven feature called Chemistry to help users overcome swipe fatigue by providing personalized interactions instead of endless swiping. Currently in testing in Australia, this feature will access users' interests and photos to improve match quality. The company aims to address user burnout amid declining subscriber numbers.
If you do, here's more
Tinder is introducing an AI feature called Chemistry to address the problem of "swipe fatigue," where users feel overwhelmed by endless profile swiping. Launched in late 2026, Chemistry uses AI to engage users through questions and, with their consent, analyzes their Camera Roll to better understand their interests and personalities. Currently, this feature is being tested in Australia, but CEO Spencer Rascoff hinted at broader applications in the future.
User engagement is a pressing issue for Tinder, which has seen a 5% year-over-year decline in new registrations and a 9% drop in monthly active users. These trends are concerning, especially as Tinder and other dating apps face challenges with subscriber retention and new sign-ups. In response, Match Group has been experimenting with AI-driven recommendations that reorder profiles shown to users, particularly women, which has contributed to slight improvements in user metrics. Additionally, Match is redesigning its platform to make user experiences more relevant and authentic, including a facial recognition feature called Face Check that has cut down on interactions with bad actors by over 50%.
Financially, Tinder reported fourth-quarter revenue of $878 million with earnings per share of 83 cents, exceeding Wall Street expectations. However, weak guidance led to initial stock declines. To enhance user engagement further, Match plans to spend $50 million on marketing for Tinder, including campaigns on platforms like TikTok and Instagram, aiming to revitalize its brand image and attract users back to the app.
Questions about this article
No questions yet.